BRIEF published on 03/17/2026 at 07:08, 2 days 16 hours ago Sartorius Stedim Biotech refines its strategy and aims for ambitious growth EBITDA Sartorius Stedim Biotech Product Portfolio Growth Objectives Biopharmaceutical Strategy
BRIEF published on 03/17/2026 at 07:08, 2 days 16 hours ago Sartorius Stedim Biotech Sets New Growth Targets with Biopharma Focus Advanced Therapies Market Expansion Growth Targets Biopharma Strategy Bioprocessing Technologies
PRESS RELEASE published on 03/17/2026 at 07:03, 2 days 16 hours ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius Stedim Biotech sharpens focus on biopharma with new growth targets and strategic initiatives to drive above-market growth and margin expansion Sartorius Stedim Biotech Strategic Initiatives Growth Targets Biopharma Above-market Growth
BRIEF published on 03/02/2026 at 16:30, 17 days 7 hours ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
BRIEF published on 03/02/2026 at 16:30, 17 days 7 hours ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
PRESS RELEASE published on 03/02/2026 at 16:25, 17 days 7 hours ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 1 month 3 days ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 1 month 3 days ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
BRIEF published on 02/16/2026 at 09:13, 1 month 3 days ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
PRESS RELEASE published on 02/16/2026 at 09:09, 1 month 3 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
Published on 03/19/2026 at 21:16, 2 hours 45 minutes ago Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 9 hours 41 minutes ago CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 10 hours 11 minutes ago Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 10 hours 31 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 10 hours 31 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 23:48, 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 1 hour 5 minutes ago Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 1 hour 12 minutes ago EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:24, 4 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/19/2026 at 18:00, 6 hours 1 minute ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 08:45, 15 hours 16 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 17 hours 1 minute ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 17 hours 1 minute ago 2025 Annual results and new strategic signature
